Kelly Financial Services’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17
| Closed | -$217 | – | 467 |
|
|
2024
Q2 | $217 | Hold |
17
| – | – | ﹤0.01% | 738 |
|
|
2024
Q1 | $378 | Hold |
17
| – | – | ﹤0.01% | 725 |
|
|
2023
Q4 | $216 | Hold |
17
| – | – | ﹤0.01% | 735 |
|
|
2023
Q3 | $335 | Hold |
17
| – | – | ﹤0.01% | 710 |
|
|
2023
Q2 | $448 | Hold |
17
| – | – | ﹤0.01% | 659 |
|
|
2023
Q1 | $973 | Hold |
17
| – | – | ﹤0.01% | 596 |
|
|
2022
Q4 | $850 | Hold |
17
| – | – | ﹤0.01% | 578 |
|
|
2022
Q3 | $1.37K | Hold |
17
| – | – | ﹤0.01% | 545 |
|
|
2022
Q2 | $1.13K | Hold |
17
| – | – | ﹤0.01% | 544 |
|
|
2022
Q1 | $1.84K | Hold |
17
| – | – | ﹤0.01% | 525 |
|
|
2021
Q4 | $1.61K | Hold |
17
| – | – | ﹤0.01% | 566 |
|
|
2021
Q3 | $1.46K | Sell |
17
-155
| -90% | -$13.3K | ﹤0.01% | 552 |
|
|
2021
Q2 | $250K | Buy |
172
+155
| +912% | +$225K | 0.01% | 274 |
|
|
2021
Q1 | $2.63K | Hold |
17
| – | – | ﹤0.01% | 476 |
|
|
2020
Q4 | $3.87K | Hold |
17
| – | – | ﹤0.01% | 404 |
|
|
2020
Q3 | $3.65K | Hold |
17
| – | – | ﹤0.01% | 370 |
|
|
2020
Q2 | $4.74K | Sell |
17
-50
| -75% | -$13.9K | ﹤0.01% | 343 |
|
|
2020
Q1 | $19.4K | Hold |
67
| – | – | 0.02% | 136 |
|
|
2019
Q4 | $19.3K | Hold |
67
| – | – | 0.01% | 164 |
|
|
2019
Q3 | $9.7K | Buy |
+67
| New | +$9.7K | 0.01% | 229 |
|